Legal Representation
Attorney
Terese Cohen
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 8, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 8, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 10, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 10, 2008 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 10, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 7, 2007 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 7, 2007 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 7, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 1, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 1, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 1, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 8, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 16, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 26, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 27, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 24, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 13, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 17, 2006 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Feb 13, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2006 | I | PAPER RECEIVED | Loading... | |
| Sep 23, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 25, 2005 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Aug 24, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 22, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 2, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular diseases, gastrointestinal diseases, inflammatory diseases, central nervous system disorders, sexual dysfunction, respiratory disorders, pulmonary disorders, blood disorders, sickle cell anemia, immune system disorders, bone disorders and urological disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
pharmaceutical research and development services
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042